European Union · Question · QUESTION_WRITTEN
E-9-2021-002429
Corona antibody test as a valuable tool in vaccination prioritization
Introduced
5 May 2021
Last action
1 July 2021 · Answer
Status
answered
Sponsors
Engin EROGLU
Subjects
Discovery layer
Source updated
1 July 2021
Records
Official question E-9-2021-002429 from European Union at European Parliament. Dated 5 May 2021. Status: answered.
Timeline
5 May 2021
Written question
Corona antibody test as a valuable tool in vaccination prioritization
Source: QUESTION_WRITTEN
1 July 2021
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Corona antibody test as a valuable tool for vaccine prioritising
QUESTION_WRITTEN · EN · 19 May 2021
Corona antibody test as a valuable tool for vaccine prioritising
QUESTION_WRITTEN · EN · 19 May 2021
Corona antibody test as a valuable tool for vaccine prioritising
QUESTION_WRITTEN · EN · 19 May 2021
Answer
QUESTION_WRITTEN_ANSWER · 1 July 2021
Corona-Antikörpertest als wertvolles Tool bei der Impf-Priorisierung
QUESTION_WRITTEN · DE · 19 May 2021
Corona-Antikörpertest als wertvolles Tool bei der Impf-Priorisierung
QUESTION_WRITTEN · DE · 19 May 2021
Corona-Antikörpertest als wertvolles Tool bei der Impf-Priorisierung
QUESTION_WRITTEN · DE · 19 May 2021
Sponsors
- Engin EROGLU · AUTHOR
- · EU_COMMISSION · ADDRESSEE
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-9-2021-002429_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-9-2021-002429
- eu · E-9-2021-002429 · source updated 1 July 2021